Today

Agents

Chat

Arena

Discover

More

App

Gyre Therapeutics Reports Second Quarter 2026 - GYRE News | Rallies

Gyre Therapeutics Reports Second Quarter 2026

GYRE•2026-08-07

Reuters brief on second-quarter results and business update

Gyre Therapeutics, Inc. (NYSE: GYRE) reported second quarter 2026 and year-to-date financial results and provided a business update.

Related News

Trade Desk Inc <TTD.O>: UBS cuts target price to $16 from $28

TTD•2026-08-07

Celsius Holdings, Inc. <CELH.O>: UBS Cuts Target Price to $44 From $50

CELH•2026-08-07

Zoetis Inc <ZTS.N>: UBS cuts target price to $80 from $85

ZTS•2026-08-07

D

Dime Commercial Bancshares director Raymond A. Nielsen disposes of 1,800 common shares worth $75,112.74

DCOM•2026-08-07

Nasdaq trade halt <MB.O> volatility trading pause at 09:31 AM

MB•2026-08-07